style="font-size:15px;"> 62 62. Fliser D, Ritz E. Serum cystatin C concentration as a marker of renal dysfunction in the elderly. Am J Kidney Dis. 2001; 37:79–83.63 63. Hollenberg NK, Adams DF, Solomon HS, et al. Senescence and the renal vasculature in normal man. Circ Res 1974; 34:309–316.
64 64. Kuchel GA. Aging and homeostatic regulation. In: Halter JB, Hazzard WR, Ouslander JG et al, eds. Hazzard’s Principles of Geriatric Medicine And Gerontology. 3rd ed. McGraw Hill; 2008.
65 65. Rule AD, Jacobson DJ, McGree ME, et al. Longitudinal changes in post‐void residual and voided volume among community dwelling men. J Urol. 2005; 174:1317–1321.
66 66. Ustinova EE, Fraser MO, Pezzone MA Cross‐talk and sensitization of bladder afferent nerves. Neurourol Urodyn. 2010; 29:77–81.
67 67. Kuchel GA, Moscufo N, Guttmann CR, et al. Localization of brain white matter hyperintensities and urinary incontinence in community‐dwelling older adults. J Gerontol. A Biol Sci Med Sci. 2009; 64:902–909.
68 68. Smith PP, Chalmers DJ, Feinn RS. Does defective volume sensation contribute to detrusor underactivity? Neurourol Urodyn. 2015; 34:752–756. doi: 10.1002/nau.22653.
69 69. Gunes S, et al. Effects of aging on the male reproductive system. J Assist Reprod Genet. 2016; 33(4):441–54.
70 70. Shirasuna K, Iwata H. Effect of aging on the female reproductive function. Contracept Reprod Med. 2017; 2:23.
71 71. Ventura MT, et al. Immunosenescence in aging: between immune cells depletion and cytokines up‐regulation. Clin Mol Allergy. 2017; 15:21.
72 72. Xia S, et al. An update on inflamm‐aging: mechanisms, prevention, and treatment. J Immunol Res. 2016:8426874.
73 73. Kevorkian RT, Morley JE. The physiology of ageing. In: Sinclair AJ, Morley JE, Vellas B, eds. Pathy’s Principles and Practice of Geriatric Medicine. 5th ed. John Wiley and Sons, Ltd. Wiley‐Blackwell; 2012:38.
74 74. Pouilles JM, Tremollieres F, Ribot C. Effect of menopause on femoral and vertebral bone loss. J Bone Miner Res. 1995; 10:1531–1536.
75 75. Todd RC, Freeman MA, Pirie CJ. Isolated trabecular fatigue fractures in the femoral head. J Bone Joint Surg Br. 1972; 54:723–728.
76 76. Oxlund H, Mosekilde L, Ortoft G. Reduced concentration of collagen reducible cross links in human trabecular bone with respect to age and osteoporosis. Bone. 1996; 19:479–484.
77 77. Nakashima T, et al. Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nat Med. 2011; 17:1231–1234.
78 78. Yeung RS. The osteoprotegerin/osteoprotegerin ligand family: role in inflammation and bone loss. J Rheumatol. 2004; 31:844–846.
79 79. Gaudio A, et al. Increased sclerostin serum levels associated with bone formation and resorption markers in patients with immobilizationinduced bone loss. J Clin Endocrinol Metab. 2010; 95:2248–2253.
80 80. Fox AJS, Bedi A, Rodeo SA. The basic science of articular cartilage. Sports Health. 2009; 1:461–468.
81 81. Antoniou J, et al. The human lumbar intervertebral disc: evidence for changes in the biosynthesis and denaturation of the extracellular matrix with growth, maturation, ageing, and degeneration. J Clin Invest. 1996; 98:996–1003.
82 82. Iannuzzi‐Sucich M, Prestwood KM, Kenny AM. Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women. J Gerontol. A Biol Sci Med Sci. 2002; 57:M772–M777
83 83. Girgis C, Mokbel N, DiGirolamo D. Therapies for musculoskeletaldisease: can we treat two birds with one stone? Curr Osteoporos Rep. 2014; 12:142–153.
84 84. Cruz‐Jentoft AJ, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019; 48(1):16–31.
85 85. Rahman I, Morrison D, Donaldson K, et al. Systemic oxidative stress in asthma, COPD, and smokers. Am J Respir Crit Care Med. 1996; 154(Pt):1055–1060.
86 86. Lambeth JD. Nox enzymes, ROS, and chronic disease: an example of antagonistic pleiotropy. Free Radic Biol Med. 2007; 43:332–347.
87 87. Kelly FJ. Vitamins and respiratory disease: antioxidant micronutrients in pulmonary health and disease. Proc Nutr Soc. 2005; 64:510–526.
88 88. Verbeken EK, Cauberghs M, Mertens I, et al. The senile lung: comparison with normal and emphysematous lungs. 1: structural aspects. Chest. 1992; 101:793–799.
89 89. Leech JA, Dullberg C, Kellie S, et al. Relationship of lung function to severity of osteoporosis in women. Am Rev Respir Dis. 1990; 141:68–71.
90 90. Swanney MP1, Ruppel G, Enright PL, et al. Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction. Thorax. 2008; 63:1046–1051.
91 91. Stubbings AK, Moore AJ, Dusmet M, et al. Physiological properties of human diaphragm muscle fibres and the effect of chronic obstructive pulmonary disease. J Physiol. 2008; 586:2637–2650.
92 92. García‐Río F, Villamor A, Gómez‐Mendieta A, et al. The progressive effects of ageing on chemosensitivity in healthy subjects. Respir Med. 2007; 101:2192–2198.
93 93. Shaykhiev R, Crystal RG. Innate immunity and chronic obstructive pulmonary disease: a mini‐review. Gerontology. 2013; 59:481–489.
94 94. Gomez CR, Boehmer ED, Kovacs EJ. The aging innate immune system. Curr Opin Immunol. 2005; 17:457–462.
95 95. Harvell JD, Maibach HI. Percutaneous absorption and inflammation in aged skin: a review. J Am Acad Dermato.l 1994; 31:1015–1021.
96 96. Oikarinen A. The aging of skin: chronoaging versus photoaging. Photodermatol Photoimmunol Photomed. 1990; 7:3–4.
97 97. Landau M. Exogenous factors in skin aging. Curr Probl Dermatol. 2007; 35:1–13.
98 98. Waller JM, Maibach HI. Age and skin structure and function, a quantitative approach (I): blood flow, pH, thickness, and ultrasound echogenicity. Skin Res Technol. 2005; 11:221–235.
99 99. Varani J, Spearman D, Perone P, et al. Inhibition of type I procollagen synthesis by damaged collagen in photoaged skin and by collagenase‐degraded collagen in vitro. Am J Pathol. 2001; 158:931–942.
100 100. Farage MA, Miller KW, Maibach HI. Degenerative changes in aging skin. In: Farage MA, Miller KW, and Maibach HI, eds. Textbook of Aging Skin. Springer‐Verlag; 2010:25–35.
CHAPTER 3 Psychological aspects of ageing
Evan T. Schulze1, Phillip Ruppert2, Gayle Heady2, and Lauren Schwarz2
1 Department of Neurology, Saint Louis University School of Medicine, St. Louis, Missouri, USA
2 Depart of Psychiatry and Behavioral Neuroscience, Saint Louis University School of Medicine, St. Louis, Missouri, USA
Introduction
Ageing is on the rise. The world population aged 65 and older is expected to nearly double
